Table 1 |.
genetic alteration | Condition | Neurodevelopmental phenotype | Developmental brain pathology | Degenerative phenotype | Degenerative brain pathology |
---|---|---|---|---|---|
Trisomy 21 | Down syndrome | Autism, intellectual disability | Small cerebrum, small cerebellum, dendritic spine abnormalities | Alzheimer disease | Alzheimer disease neuropathological changes |
FMR1 full mutation (>200 repeats) | Fragile X syndrome | Autism, intellectual disability, attention deficit hyperactivity disorder | Heterotopias, enlarged caudate nucleus, dendritic spine abnormalities | Parkinsonism, ataxia | Largely unknown |
FMR1 pre-mutation (55–200 repeats) | Fragile X-associated tremor/ataxia syndrome | Autism, anxiety, attention deficit hyperactivity disorder in a subset | – | Ataxia, intention tremor, parkinsonism | White matter degeneration, Purkinje cell loss, eosinophilic inclusions within neurons and glia |
22q11.2 deletion | Velocardiofacial syndrome | Learning disabilities, intellectual disability, schizophrenia | Variable: polymicrogyria, heterotopias, developmental microvasculopathy | Early-onset parkinsonism | Nigral degeneration with Lewy body formation |
c.598G>A mutation in PPP2R5D | NA | Intellectual disability | Macrocephaly | Early-onset parkinsonism | Nigral degeneration in the absence of Lewy body pathology |
NR4A2 variants | NA | Intellectual disability | – | Early-onset parkinsonism | Yet to be studied post-mortem |
RAB39B variants | NA | Intellectual disability | – | Early-onset parkinsonism | Nigral degeneration with Lewy body formation |
H3F3A and H3F3B variants | NA | Intellectual disability | Yet to be studied post-mortem | Global neurodegeneration | Yet to be studied post-mortem |
KIF1A variants | KIF1A-associated neurological disorder | Intellectual disability, seizures, spastic paraplegia | Microcephaly | Optic nerve atrophy, cerebral and cerebellar atrophy | Cerebellar atrophy, dentate nucleus and inferior olivary neuronal loss |
HTT expansions | Huntington disease | Reduced brain growth compared with control individuals, epilepsy in ~25% individuals with juvenile-onset Huntington disease (age of onset <20 years) | Brain malformations in a subset, usually single unilateral heterotopias | Psychiatric disease, cognitive decline, chorea | Striatal degeneration, diffuse brain atrophy, formation of huntingtin aggregates |
NA, not applicable.